Evaluation of protein-denaturing immunoassays for avidity of immunoglobulin G to rubella virus-Reference-Cited by-同舟云学术

Evaluation of protein-denaturing immunoassays for avidity of immunoglobulin G to rubella virus

Published:1994 Issue:1 Volume:8 Page:16-21
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J. Clin. Lab. Anal.

Author:

Polanec J.,Seppälä I.,Rousseau S.,Hedman K.

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Reference24 articles.

1. : Overview: Introduction to methods used to study the affinity and kinetics of antibody-antigen reactions. In: Handbook of Experimental Immunology in Four Volumes. Vol. 1: Immunochemistry , , eds Fourth edition. Blackwell Scientific Publications, Oxford, 1986, p 25.1–25.30.

2. Measurement of the Affinity of Antiviral Antibodies

3. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed

4. Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays

5. SEROLOGICAL DISTINCTION BETWEEN PRIMARY RUBELLA AND REINFECTION

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ebola Virus–Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean Cohort;The Journal of Infectious Diseases;2024-05-27

2. Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience;Clinical and Experimental Medicine;2022-09-08

3. Effects of the age of vaccination on the humoral responses to a human papillomavirus vaccine;npj Vaccines;2022-03-15

4. Efficacy of anti-SARS-CoV-2 mRNA vaccine in systemic autoimmune disorders: induction of high avidity and neutralising anti-RBD antibodies;RMD Open;2021-12

5. BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers;Vaccines;2021-06-18